Schroders Capital invests more in Memo Therapeutics AG
LONDON: Schroders Capital Global Innovation Trust plc announced its follow-on investment in Memo Therapeutics AG, a late clinical-stage biotech company based in Switzerland. The Company...
Schroders Capital Global Innovation Trust makes investment in Memo Therapeutics
LONDON: Schroders Capital Global Innovation Trust has made a commitment of CHF 0.9 million (£0.8 million) to Memo Therapeutics AG, a Switzerland-based clinical-stage biopharmaceutical company....